CRISPR QC articles

The Clinical CRISPR Successes Are Stacking Up. But Where’s the Emphasis on Quality Control?

In mid-September, Intellia released some promising data on two of their CRISPR-based therapeutics. These results are a significant milestone for genome editing and validation of its effectiveness in the clinic.

However, the safety of CRISPR-based therapeutics has been a major concern and part of a larger con